Lungs News and Research

RSS
Lung transplants: Doing more is better and safer

Lung transplants: Doing more is better and safer

Opposite approach to asthma treatment may be in order

Opposite approach to asthma treatment may be in order

Researchers refine breast cancer identification

Researchers refine breast cancer identification

Obesity may be contagious!

Obesity may be contagious!

Stromedix awarded U.S. patent for antibody-based therapeutics

Stromedix awarded U.S. patent for antibody-based therapeutics

Study links smoking with most male cancer deaths

Study links smoking with most male cancer deaths

Blocked Interleukin 21 protein prevents Lupus in mouse model

Blocked Interleukin 21 protein prevents Lupus in mouse model

Measurement of kidney function in children with kidney disease improved

Measurement of kidney function in children with kidney disease improved

Study examines racial disparities in survival among patients diagnosed with lung cancer

Study examines racial disparities in survival among patients diagnosed with lung cancer

Cream containing tretinoin associated with death in clinical trial, but relationship does not appear causal

Cream containing tretinoin associated with death in clinical trial, but relationship does not appear causal

Less severe first heart attacks linked to decline in coronary heart disease deaths

Less severe first heart attacks linked to decline in coronary heart disease deaths

Three new genetic variations that increase the risk of obesity

Three new genetic variations that increase the risk of obesity

MRSA's weak point visualised by scientists

MRSA's weak point visualised by scientists

Higher mortality among unscreened children

Higher mortality among unscreened children

Half of people 50 years and younger with low 10-year risk of CVD have high lifetime risk

Half of people 50 years and younger with low 10-year risk of CVD have high lifetime risk

Cell Therapeutics targeting potential Zevalin label expansion,

Cell Therapeutics targeting potential Zevalin label expansion,

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Time of day influences response to chemotherapy

Time of day influences response to chemotherapy

Discovery of potential biomarker for smoking-related lung diseases

Discovery of potential biomarker for smoking-related lung diseases

Vicks VapoRub may create respiratory distress in young children

Vicks VapoRub may create respiratory distress in young children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.